Cancer cells with alternative lengthening of telomeres do not display a general hypersensitivity to ATR inhibition

Telomere maintenance is a hallmark of cancer as it provides cancer cells with cellular immortality. A significant fraction of tumors uses the alternative lengthening of telomeres (ALT) pathway to elongate their telomeres and to gain an unlimited proliferation potential. Since the ALT pathway is uniq...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Katharina I Deeg, Inn Chung, Caroline Bauer, Karsten Rippe
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Frontiers Media S.A. 2016-08-01
Ráidu:	Frontiers in Oncology
Fáttát:	ALT VE-821 Alternative lengthening of telomeres ATR inhibitor ataxia telangiectasia- and RAD3-related (ATR)
Liŋkkat:	http://journal.frontiersin.org/Journal/10.3389/fonc.2016.00186/full
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!